Skip to content
Peptigraph home

SLU-PP-332 for Weight Loss: What the Evidence Shows

What human and animal studies show about SLU-PP-332 for weight loss, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureERR agonist (not a peptide)Updated
Strongest evidence
Animal
Human studies
None found
with an outcome for weight loss, in our evidence file (PubMed search, 2 Oct 2026)
Animal studies
1
with an outcome for weight loss, in our evidence file (PubMed search, 2 Oct 2026)
Studies we summarised
1
with an outcome for weight loss

Evidence for weight loss

Each row is an outcome related to weight loss from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

SLU-PP-332 for weight loss: outcomes in published studies
OutcomeResultStudy typeSource
Energy expenditure and fatty acid oxidationIn mice, SLU-PP-332 increased energy expenditure and fatty acid oxidation, mimicking exercise effects on whole-body metabolism.Animal · mouse (not a human result)The Journal of pharmacology and experimental therapeutics 2024, PMID 37739806
Fat mass and insulin sensitivityThe ERR agonist reduced obesity and improved insulin sensitivity in mouse models of metabolic syndrome.Animal · mouse (not a human result)The Journal of pharmacology and experimental therapeutics 2024, PMID 37739806

SLU-PP-332 and weight loss are not in our PubMed count ledger yet; the rows above come from our evidence file (PubMed search, 2 Oct 2026). Grades follow our evidence scale.

How strong is it?

Strongest evidence:Animal evidence, 2 of 4The Journal of pharmacology and experimental therapeutics 2024, PMID 37739806

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Other peptides people research for weight loss

SemaglutideTirzepatideRetatrutideOrforglipronSermorelinTesamorelinhCGMOTS-c
All peptides for weight loss, compared

Common questions

Does SLU-PP-332 help with weight loss?

The strongest study we summarise for weight loss is animal evidence, across 1 study with an outcome for weight loss. That is not proof it works in people.

Is SLU-PP-332 approved for weight loss?

SLU-PP-332 is Not FDA approved · research chemical. Which conditions that approval covers is set by the label; use for anything else is off-label.

What is the best peptide for weight loss?

There is no single answer. Our weight loss overview compares each candidate by evidence grade and legal status rather than by popularity.

More on SLU-PP-332

DosageDoses used in published studies, with the source for each.CalculatorVial, water and dose to syringe units.Side effectsWhat labels and studies report, and what is unknown.ResultsStudy outcomes and when they were measured.PricePrice per mg and per week from dated listings. No vendor links.Half-lifeWhat is measured, by route, and what is not.

Sources

  1. 1A Synthetic ERR Agonist Alleviates Metabolic Syndrome.The Journal of pharmacology and experimental therapeutics · 2024PMID 37739806Accessed 2 Oct 2026

Found an error? Report a correction.